These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20823654)

  • 1. Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation.
    Nakanishi H; Muta T; Fujisaki T; Yoshitomi R; Kubo T; Yokota E
    Intern Med; 2010; 49(17):1901-5. PubMed ID: 20823654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
    Birnkrant D; Cox E
    N Engl J Med; 2009 Dec; 361(23):2204-7. PubMed ID: 19884645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain].
    Bonastre J; Suberviola B; Pozo JC; Guerrero JE; Torres A; Rodríguez A; Martín-Loeches I;
    Med Intensiva; 2012 Apr; 36(3):193-9. PubMed ID: 22341559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
    Huang SF; Fung CP; Perng DW; Wang FD
    J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient.
    Flagg A; Danziger-Isakov L; Foster C; Nasman C; Smedira N; Carl J; Kwon C; Davis S; Boyle G
    J Heart Lung Transplant; 2010 May; 29(5):582-4. PubMed ID: 20044274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A (H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center.
    Hou X; Guo L; Zhan Q; Jia X; Mi Y; Li B; Sun B; Hao X; Li H
    Artif Organs; 2012 Sep; 36(9):780-6. PubMed ID: 22747918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peramivir and its use in H1N1 influenza.
    Castillo R; Holland LE; Boltz DA
    Drugs Today (Barc); 2010 Jun; 46(6):399-408. PubMed ID: 20571608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.
    Sugaya N; Kohno S; Ishibashi T; Wajima T; Takahashi T
    Antimicrob Agents Chemother; 2012 Jan; 56(1):369-77. PubMed ID: 22024821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome caused by novel 2009 influenza A (H1N1) virus].
    Zhan QY; Sun B; Tong ZH; Guo LM; Xu L; Zhu X; Jia XJ; Wang C
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3262-6. PubMed ID: 22333146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.
    Sihler KC; Park PK
    Surg Infect (Larchmt); 2011 Apr; 12(2):151-8. PubMed ID: 21545282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary complications from pandemic AH1N1 influenza: clinical-radiological features].
    Bellissima P; Bellissima G
    Infez Med; 2011 Mar; 19(1):20-7. PubMed ID: 21471743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pathological characteristics and management of acute respiratory distress syndrome resulting from influenza A (H1N1) virus.
    Homsi S; Milojkovic N; Homsi Y
    South Med J; 2010 Aug; 103(8):786-90; quiz 791-2. PubMed ID: 20622733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1)-associated acute respiratory distress syndrome.
    Combes A; Pellegrino V
    Semin Respir Crit Care Med; 2011 Apr; 32(2):188-94. PubMed ID: 21506055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.
    Roncon-Albuquerque R; Basílio C; Figueiredo P; Silva S; Mergulhão P; Alves C; Veiga R; Castelo-Branco S; Paiva L; Santos L; Honrado T; Dias C; Oliveira T; Sarmento A; Mota AM; Paiva JA
    J Crit Care; 2012 Oct; 27(5):454-63. PubMed ID: 22386225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of extracorporeal membrane oxygenation (ECMO) in the treatment of acute respiratory distress syndrome due to pandemic influenza].
    Knapik P; Przybylski R; Nadziakiewicz P; Koba R; Maciejewski T; Borowicz M; Włoczka G; Pawlak S; Zembala M
    Kardiol Pol; 2011; 69(4):416-20. PubMed ID: 21523689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.